CIBC Global Asset Management »

Adagio Therapeutics shares owned by CIBC Global Asset Management

Quarter-by-quarter ownership of Adagio Therapeutics (IVVD) shares owned by CIBC Global Asset Management from 13F filings

Historical chart of CIBC Global Asset Management investment in Adagio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adagio Therapeutics held by CIBC Global Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adagio Therapeutics by CIBC Global Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $38k 15k 2.47

More positions owned by CIBC Global Asset Management

Rbc Cad (RY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Microsoft Corporation (MSFT)
Cibc Cad (CM)
Barrick Mng Corp Com Shs (B)
Amazon (AMZN)
Agnico (AEM)
Bank Of Montreal Cadcom (BMO)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Bk Nova Cad (BNS)
Shopify Cl A Sub Vtg Shs (SHOP)
Alphabet Cap Stk Cl A (GOOGL)
Enbridge (ENB)

View all positions for CIBC Global Asset Management

Top funds holding Adagio Therapeutics

Henderson Group
Maverick Capital
RA Capital Management
Point72 Asset Management
Mithril II GP
Vanguard Group
Driehaus Capital Management
M28 Capital Management
Saturn V Capital Management
Soleus Capital Management
Eventide Asset Management
State Street Corporation
Siren
ADAR1 Capital Management
BlackRock

View all funds holding Adagio Therapeutics